US Stock MarketDetailed Quotes
ABSI Absci Corp
- 3.070
- +0.130+4.42%
Trading Nov 29 12:43 ET
352.61MMarket Cap-3301P/E (TTM)
3.080High2.905Low389.54KVolume2.970Open2.940Pre Close1.17MTurnover0.45%Turnover RatioLossP/E (Static)114.86MShares6.72052wk High1.75P/B264.83MFloat Cap1.74052wk Low--Dividend TTM86.26MShs Float31.530Historical High--Div YieldTTM5.95%Amplitude1.111Historical Low3.010Avg Price1Lot Size
About Absci Corp Company
Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.
Company Profile
SymbolABSI
Company NameAbsci Corp
Listing DateJul 22, 2021
Issue Price16.00
Founded2011
CEOMr. Sean McClain
MarketNASDAQ
Employees156
Fiscal Year Ends12-31
Address18105 SE Mill Plain Boulevard
CityVancouver
ProvinceWashington
CountryUnited States of America
Zip Code98683
Phone1-360-949-1041
Websitehttp://www.absci.com
Company Executives
- Name
- Position
- Salary
- Sean McClain
- Chief Executive Officer and Director
- 4.01M
- Dr. Andreas Busch, PhD
- Chief Innovation Officer
- 4.73M
- Dr. Zachariah Jonasson, PhD
- Chief Financial Officer and Chief Business Officer
- 155.12K
- Todd Bedrick
- Chief Accounting Officer
- --
- Dr. Ivana Magovcevic-Liebisch, J.D.,PhD
- Chairman of the Board
- 203.34K
- Frans Van Houten
- Director
- --
- Joseph Sirosh, PhD
- Independent Director
- 297.86K
- Karen K. McGinnis
- Lead Independent Director
- 172.49K
- Professor Menelas Pangalos, PhD
- Independent Director
- --
- Daniel A. Rabinovitsj
- Independent Director
- 119.00K
- Amrit Nagpal
- Independent Director
- 106.82K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data